Skip to main content

Advertisement

Table 7 Nine-year costs for zeaxanthin and no zeaxanthin triple therapy (2015 US Real dollars, discounted at 3 % annually)

From: Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis

Model No zeaxanthin treatment cohort Triple combination therapy with zeaxanthin (9 years of zeaxanthin) Triple combination therapy with zeaxanthin (2 years of zeaxanthin)
First-eye, second-eye or combined-eye model: the same for all $9540 $10,440 $8222
  1. Combined-eye model = 66 % 1st-eye model and 34 % 2nd-eye model
  2. TTZ triple combination with zeaxanthin, TT triple combination therapy